Brean Murray Carret & Co. Starts Boston Scientific (BSX) at Hold; No Clear Path to Growth Reacceleration & Mgmt Transition Makes for Tough Outlook
Go back to Brean Murray Carret & Co. Starts Boston Scientific (BSX) at Hold; No Clear Path to Growth Reacceleration & Mgmt Transition Makes for Tough Outlook| Boston Scientific (NYSE: BSX) | Delayed: 49.79 -2.22 (4.27%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $52.01 | 52 Week High | $24.79 | |||
| Open | $51.64 | 52 Week Low | $15.67 | |||
| Day High | $51.80 | P/E | N/A | |||
| Day Low | $49.69 | EPS | $-0.09 | |||
| Volume | 13,851,988 | |||||

